Search results
Showing 706 to 720 of 1372 results for social care
of medicines and improving patient-reported outcomes, compared with usual care or other intervention in the UK setting? Any explanatory...
Evidence-based recommendations on durvalumab (Imfinzi) for locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation in adults.
research, see the rationale section on coordinating education, health and care (EHC) plan process changes with local services, training...
Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care...
Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care.
point in the care pathway the views and experiences expressed relate to. As such, it is difficult to fully break down the experience of...
medicines and medicines-related patient safety incidents, compared with usual care or other interventions, in children? Any explanatory...
This guideline covers diagnosing and treating fertility problems. It aims to reduce variation in practice and improve the way fertility problems are investigated and managed.
delivered alone or in combination (in conjunction with standard care) compared with standard care alone for young people...
Early value assessment (EVA) guidance on digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people....
View recommendations for HTE17Show all sections
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome (TA615)
Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Lennox–Gastaut syndrome in people aged 2 years and older.
Recommendation ID NG181/6 Question Is an integrated care system effective at promoting successful progress for people with complex...
to address the needs of older people. It is also unclear if health and social care practitioners fully understand the purpose of the...
Dupilumab for treating moderate to severe prurigo nodularis (TA955)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe prurigo nodularis in adults when systemic treatment is suitable.
This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.